Evidence map›Paper›PMID 38391112›Full record

Observational studyRheumatology (Oxford, England)2025

Impact on patient outcomes of spondyloarthritis-inflammatory bowel disease multi-disciplinary meetings.

Sarah Sayers, Danielle Lam, Qutab Shah, Jobie Evans, Miles Parkes, Carmel Stober, Joanne Rimmer, Gavin Clunie, Tania-Elena Gudu, Denise Rosembert and 5 more

Open access · hybridAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Rheumatology (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 3 countries.

Sarah SayersRheumatology Research Unit, Department of Medicine, University of Cambridge, Cambridge, UK.ORCID 0009-0003-8931-7361
Danielle LamDepartment of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Qutab ShahRheumatology Research Unit, Department of Medicine, University of Cambridge, Cambridge, UK.
Jobie EvansRheumatology, Addenbrooke's Hospital, Cambridge, UK.
Miles ParkesDepartment of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Carmel StoberDepartment of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Joanne RimmerDepartment of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Gavin ClunieDepartment of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Tania-Elena GuduDepartment of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID 0000-0002-8973-323X
Denise RosembertDepartment of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Sreedhar SubramanianDepartment of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Stephanie Brookes-JonesDepartment of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Stephen MossDepartment of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Tim RaineDepartment of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Deepak JadonRheumatology Research Unit, Department of Medicine, University of Cambridge, Cambridge, UK.ORCID 0000-0003-0600-4566
Cambridge University Hospitals NHS Foundation Trust · GBUniversity of Cambridge · GBAddenbrooke's Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess the impact on patient outcomes of the spondyloarthritis (SpA) and inflammatory bowel disease (IBD) multidisciplinary team (MDT) meetings in a large university hospital.

methodsA single-centre retrospective observational case-note review was conducted assessing the outcome of all 226 cases discussed at the SpA-IBD MDT meetings in a large UK university hospital between 2017 and 2022.

resultsA total of 226 patients were discussed. It was deemed that 97% of MDT meetings helped to improve communication between teams, and 100% were educational. A total of 57% of discussions led to an instant change of disease management, while 40% of discussions resulted in a treatment plan that avoided the use of dual advanced therapy. This improved patient safety by reducing immunosuppression. The MDT meetings were highly cost and time efficient; 125 referrals between specialists were avoided, and in 51 cases there was a significant chance of reducing future drug costs. A timely investigation or appointment was arranged following 50% of MDT discussions, helping to clarify the diagnosis and optimize patient care. Nine percent of meetings enabled drugs to be prescribed to patients that are not yet licensed for the other speciality, thereby improving treatment options available in the management of complex cases.

conclusionThe MDT meetings have been beneficial for patients, the clinical team and the institution. This approach might be considered by other rheumatology and gastroenterology departments.

Indexed as

Inflammatory Bowel DiseasesPatient Care TeamSpondylarthritisAdultFemaleHumansInterdisciplinary CommunicationMaleMiddle AgedRetrospective StudiesCrohn’s diseaseinflammatory bowel diseasemultidisciplinaryspondyloarthritisulcerative colitis

Identifiers

PMID38391112
PMCPMC11781571
OpenAlexW4392103652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.